Cite This        Tampung        Export Record
Judul Nutritional Management of Cystic Fibrosis / Edited by: Maria R. Mascarenhas; Jessica Alvarez
Pengarang Mascarenhas, Maria R.
Alvarez, Jessica
EDISI -
Penerbitan Basel : MDPI, 2023
Deskripsi Fisik 210p. :ill.
ISBN 978-3-0365-6268-1
Subjek CYSTIC FIBROSIS
TRACE ELEMENTS IN NUTRITION
DIETARY SUPPLEMENTS
Catatan Cystic Fibrosis is an inherited disease that starts in utero. It is caused by a defective protein called the CF transmembrane conductance regulator (CFTR) and while the effects are seen throughout the body, changes in the lungs, gastrointestinal tract, pancreas and liver primarily impact nutritional status. Survival and pulmonary function have been linked to nutritional status. Malnutrition and growth failure were historically the hallmark of disease. Patients with pancreatic insufficiency require pancreatic enzyme replacement therapy and fat-soluble vitamin supplements. With improvements in many areas including newborn screening, nutrition supplements, pancreatic enzymes, CFTR modulator drugs, inhaled antibiotics and mucolytics, life expectancy has increased. In this issue, we will review the latest information in children and adults regarding important factors that play a role in optimizing nutrition status, including body composition, the gut microbiome, food security, pancreatic enzyme replacement therapy
Bentuk Karya Tidak ada kode yang sesuai
Target Pembaca Tidak ada kode yang sesuai
Lokasi Akses Online https://directory.doabooks.org/handle/20.500.12854/100833
https://oer.unair.ac.id/files/original/96cacdd4dfa0c7bed4c6fae7b8ce3b46.pdf

 
No Barcode No. Panggil Akses Lokasi Ketersediaan
296325192 613 Nut Baca Online Perpustakaan Pusat - Online Resources
Ebook
Tersedia
Tag Ind1 Ind2 Isi
001 INLIS000000000161691
005 20250515092133
007 ta
008 250515################|##########|#|##
020 # # $a 978-3-0365-6268-1
035 # # $a 0010-0525000463
082 # # $a 613
084 # # $a 613 Nut
245 # # $a Nutritional Management of Cystic Fibrosis /$c Edited by: Maria R. Mascarenhas; Jessica Alvarez
250 # # $a -
260 # # $a Basel :$b MDPI,$c 2023
300 # # $a 210p. : $b ill.
505 # # $a Cystic Fibrosis is an inherited disease that starts in utero. It is caused by a defective protein called the CF transmembrane conductance regulator (CFTR) and while the effects are seen throughout the body, changes in the lungs, gastrointestinal tract, pancreas and liver primarily impact nutritional status. Survival and pulmonary function have been linked to nutritional status. Malnutrition and growth failure were historically the hallmark of disease. Patients with pancreatic insufficiency require pancreatic enzyme replacement therapy and fat-soluble vitamin supplements. With improvements in many areas including newborn screening, nutrition supplements, pancreatic enzymes, CFTR modulator drugs, inhaled antibiotics and mucolytics, life expectancy has increased. In this issue, we will review the latest information in children and adults regarding important factors that play a role in optimizing nutrition status, including body composition, the gut microbiome, food security, pancreatic enzyme replacement therapy, growth and bone health, and micronutrient abnormalities. Pediatric and adult providers both need to be aware of the nuances of care as more patients with CF become adults. Optimizing nutritional status, anticipating and preventing the complications of CF will result in best management practice.
650 # # $a CYSTIC FIBROSIS
650 # # $a DIETARY SUPPLEMENTS
650 # # $a TRACE ELEMENTS IN NUTRITION
700 1 # $a Alvarez, Jessica
700 1 # $a Mascarenhas, Maria R.
856 # # $a https://directory.doabooks.org/handle/20.500.12854/100833
856 # # $a https://oer.unair.ac.id/files/original/96cacdd4dfa0c7bed4c6fae7b8ce3b46.pdf
990 # # $a 296325192
Content Unduh katalog